Ergocalciferol in Chronic Kidney Disease

Completed

Conditions studied: Chronic Kidney Disease

In brief

To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4

Key facts

Study ID

NCT00411294

Run by

Saint Louis VA Medical Center

Last updated by the study team

2006-12-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels >70 pg/ml.

You may not qualify if…

• Patients who are on any form of active vitamin treatment

Where it is running

• Saint Louis VA Medical Center — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.